• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

    41.51 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 44
    Open 41.51
    Bid (Size) 41.72 (200)
    Ask (Size) 47.00 (200)
    Prev. Close 41.51
    Today's Range 41.51 - 41.51
    52wk Range 1.865 - 48.26
    Shares Outstanding 61,071,897
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
    Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +3.5%
    +3.5%
    1 Month
    +12.7%
    +12.7%
    3 Month
    +61.0%
    +61.0%
    6 Month
    +449.1%
    +449.1%
    1 Year
    +1124.5%
    +1124.5%

    More News

    Read More
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
    Via Stocktwits
    News headline image
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Announces Pricing of Upsized $650 Million Public Offering
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Announces Proposed Public Offering
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades ↗
    Via Benzinga
    News headline image
    Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Terns Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Terns Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Terns Pharmaceuticals, Inc. - Common Stock trade on?
    Terns Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock is TERN on the Nasdaq Stock Market
    What is the current price of Terns Pharmaceuticals, Inc. - Common Stock?
    The current price of Terns Pharmaceuticals, Inc. - Common Stock is 41.51
    When was Terns Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Terns Pharmaceuticals, Inc. - Common Stock was at 03/03/26 04:00 PM ET
    What is the market capitalization of Terns Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Terns Pharmaceuticals, Inc. - Common Stock is 2.54B
    How many shares of Terns Pharmaceuticals, Inc. - Common Stock are outstanding?
    Terns Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.